Serial Number 88039087
Registration 5939135
702

Registration Progress

Application Filed
Jul 16, 2018
Under Examination
Mar 5, 2019
Approved for Publication
Jan 8, 2019
Published for Opposition
Jan 8, 2019
Registered
Dec 17, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-17)
Due: Dec 17, 2025 40 days

Trademark Image

Basic Information

Serial Number
88039087
Registration Number
5939135
Filing Date
July 16, 2018
Registration Date
December 17, 2019
Published for Opposition
January 8, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
702
Status Date
Aug 14, 2025
Registration
Registered
Classes
005 010

Rights Holder

EyePoint Pharmaceuticals US, Inc.

03
Address
Suite A210
480 Pleasant Street, Suite B300
Watertown, MA 02472

Ownership History

EyePoint Pharmaceuticals US, Inc.

Original Applicant
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Owner at Publication
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Kimberly Jarman, Esq.

USPTO Deadlines

Next Deadline
40 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-12-17)
Due Date
December 17, 2025
Grace Period Ends
June 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Aug 14, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 14, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 13, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 9, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 17, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 28, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 28, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 28, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 28, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 28, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 17, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 15, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 14, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 25, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 24, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 24, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 29, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 26, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 26, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 8, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 8, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 22, 2019 IUAF S USE AMENDMENT FILED Loading...
Mar 22, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 5, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 8, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 19, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 30, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 9, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 9, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 9, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 9, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 9, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 2, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 20, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 19, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 19, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions of the eyes; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of eye diseases and conditions
First Use Anywhere: Feb 28, 2019
First Use in Commerce: Feb 28, 2019
Class 010
House mark for sustained drug delivery systems for pharmaceuticals
First Use Anywhere: Feb 28, 2019
First Use in Commerce: Feb 28, 2019

Additional Information

Design Mark
The mark consists of a circle formed by two crescent shapes, one on the lower left in orange and one on the upper right in purple. The points of the two crescent shapes meet at the upper left and lower right, forming an open oval-shaped space between them angled from the upper left to the lower right. In the oval-shaped space is a magenta circle, shaded darker near the bottom and with a lighter-shaded highlight near the upper right, creating the impression of a sphere. The magenta circle is partially blocked by the orange crescent at the lower left and partially blocks the purple crescent at the upper right, such that it appears to be behind the orange crescent and in front of the purple crescent. The color white represents background color and is not claimed as a feature of the mark.
Color Claim
The color(s) orange, purple, and magenta is/are claimed as a feature of the mark.

Classification

International Classes
005 010